Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Ibrutinib“
Suchtreffer
Begriffe & Kennungen
Imbruvica · 4.5 · 51 Agents that may increase ibrutinib plasma concentrations Concomitant use of IMBRUVICA and medicinal product
Eintrag öffnenImbruvica · 4.5 · 52 Agents that may have their plasma concentrations altered by ibrutinib Ibrutinib is a P-gp and breast cancer
Eintrag öffnenImbruvica · 4.5 · 8 Agents that may decrease ibrutinib plasma concentrations Administration of IMBRUVICA with inducers of CYP3A4
Eintrag öffnenImbruvica · 4.5 · Agents that may decrease ibrutinib plasma concentrations Administration of IMBRUVICA with inducers of CYP3A4 c
Eintrag öffnenImbruvica · 4.5 · Agents that may have their plasma concentrations altered by ibrutinib Ibrutinib is a P-gp and breast cancer re
Eintrag öffnenImbruvica · 4.5 · Agents that may increase ibrutinib plasma concentrations Concomitant use of IMBRUVICA and medicinal products t
Eintrag öffnenImbruvica · 4.5 · Ibrutinib has a pH dependent solubility, with lower solubility at higher pH. A lower Cmax was observed in fast
Eintrag öffnenImbruvica · 4.5 · Ibrutinib has a pH dependent solubility, with lower solubility at higher pH. A lower Cmax was observed in fast
Eintrag öffnenImbruvica · 4.5 · Ibrutinib is primarily metabolised by cytochrome P450 enzyme 3A4 (CYP3A4).
Eintrag öffnenImbruvica · 4.5 · Ibrutinib is primarily metabolised by cytochrome P450 enzyme 3A4 (CYP3A4).
Eintrag öffnenImbruvica · 4.5 · In a drug interaction study in patients with B-cell malignancies, a single 560 mg dose of ibrutinib did not ha
Eintrag öffnenImbruvica · 4.5 · In a drug interaction study in patients with B-cell malignancies, a single 560 mg dose of ibrutinib did not ha
Eintrag öffnenImbruvica · 4.5 · In studies of ibrutinib (420 mg) in combination with venetoclax (400 mg) in CLL patients, an increase in venet
Eintrag öffnenImbruvica · 4.5 · In studies of ibrutinib (420 mg) in combination with venetoclax (400 mg) in CLL patients, an increase in venet
Eintrag öffnenImbruvica · 4.8 · 53 Tabulated list of adverse reactions Adverse reactions in patients treated with ibrutinib for B-cell maligna
Eintrag öffnenImbruvica · 4.8 · Tabulated list of adverse reactions Adverse reactions in patients treated with ibrutinib for B-cell malignanci
Eintrag öffnenKaletra · 4.5 · 14 Ibrutinib Serum concentrations may be Co-administration of ibrutinib and increased due to CYP3A Kaletra may
Eintrag öffnenNorvir · 4.5 · Ibrutinib Serum concentrations of ibrutinib may be increased due to CYP3A inhibition by ritonavir, resulting i
Eintrag öffnenRhapsido · 4.5 · 4 In a drug-interaction study, the effect of administration of remibrutinib (100 mg twice daily) on the pharma
Eintrag öffnenRhapsido · 4.5 · Active substances that may decrease remibrutinib blood concentrations
Eintrag öffnen